Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
More than $20M dollar volume traded today. That’s insane!
Just 50K shares?? I have 1.5M now
I bought using TD thinkorswim no problem
He did say “significant” assets
Nah this is being accumulated heavily. See you at .05!
Don’t think so!
The sumcoins were all in the last Q back in 2019! Just read! It’s DD!
It’s all going to be filings!!!!! It’s coming!!!!!! Today!
Huge update today! Significant assets! Colony’s to adopt green energy solar to mine more crypto’s. Already own 52677+ sumcoins worth $44M now.
$1 tomorrow
Don’t you worry. CEO is fine. $50M assets all locked up in the treasury. Can’t touch them until disclosure statements. It’s all locked up in the safety box, the treasury.
It’s the rule you have follow or else CEO will get jailed by SEC. it’s as simple as that.
Those 52766 sum coins are locked up in the company’s treasury.
Exchange rate sumcoin to Bitcoin
https://walletinvestor.com/converter/sumcoin/bitcoin/1
This is one place where you can buy and sell sumcoin, https://coincodex.com/crypto/sumcoin/exchanges/
Sumcoin has exceeded 24,503,080 transactions. http://suminsight.com/
These sumcoins are locked up in the treasury as filed in the quarterly reports in 2019.
Be ready. I think they are owning more than 52,776 sumcoins they reported in the 2019 filings.
“Nutra has potential but the company has to be cleaned up before it can do well.”
So you mean by the time they regain SEC compliance, they will be trading .10?
No debt, fully funded, patents renewed, auditors hired, SEC lawyers hired, IP attorneys hired, manufacturing busy, warehouse busy, shipping and packing busy, lab busy, collaboration with government agencies, selling on Amazon, Walmart, and etc, new distributors, all these not fitting in your “cleaned up” description?
It’s good people moving on. This hasn’t really started yet. Will see 500M per day volume coming. Shares mostly locked.
So much coming! Going to a real good one next few weeks.
You totally nailed it here. and that’s why I’m here :)
“we know now that it looks like an Nutra Pharma secured $3 million to start and finish up their clinical trials for their biggest drug. We also find out, that they are in talks with defense department affiliates because that same drug also turns out provides some sort of treatment/immunity against nerve agents.
THAT is what those big buyers knew and bought up 1 billion shares worth of stock for. “
This one is going to take everyone by surprise in OTC. Too much going on behind the scene over the past years. Company now going full transparency mode. They are funded very well this time around. Time to go kabooms.
Impressive resume by John Rabbitt the director of finance at AppSwarm Inc.
Mr. Rabbitt is a seasoned business veteran having worked with Fortune 500 firms including The Pillsbury Company and PepsiCo, and has served in CEO, COO and CFO positions for firms ranging from $5,000,000 to $300,000,000 annual revenue. This experience is enhanced by a twenty year career with one of America’s most successful Entrepreneurs (Forbes102nd wealthiest U.S.A. person in 2008) where John was directly involved with numerous acquisitions and served in executive capacities for several multinational subsidiaries. John played a key role in assisting the growth of MEI Corporation from $20 million annual revenue to $850 million annual revenue in nine years, at which time it was acquired by PepsiCo.
Going to run crazy big time with what they’ve got in the sleeves.
He actually said over $1.4M in inventory and private label products! This is going to go sky rocketing when they drop more filings to get current.
Here you go: https://fintel.io/so/us/nphc
CEO and hedge funds holding 54% of total OS. Share reduction could be in the work also.
Massive warehouse with over $1.3M in retail value of products!!! This is massive!
This shareholders letter has set the tone of what’s going to come. Huge! Everyone invested here should read into it. Remember all previously announced deals are still in place. Pending funding arrangement to be announced soon.
https://www.otcmarkets.com/filing/html?id=14688712&guid=sn5aUahaujsWLyh
This is getting loaded.
Watch out for the funding announcement. Bird chirping for March.
2FA can be easily implemented. LOL and there are a ton of 2FA third party plug-in you can integrate. Come on. This is not even a thing to raise here.
Based on the committed purchases - a substantial backlog of order worth $65M - announced and written in all their financial reports. Pending funding to kick off the massive production. Funding arrangement according to the shareholders letter has already been found. In the process of sorting out the details and will be announced soon.
$2 billion market cap coming....because
"2021 the best year ever for our shareholders, our customers, and our patients" stated by the company.
1. Nutra Pharma owns over 20 patents and trademarks as well as 119 internet domains.
2. These patents are built around their development of treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenoleukodystrophy(ALS), Adrenomyeloneuropathy(AMN), Rheumatoid Arthritis (RA), Pain, and Myasthenia Gravis (MG).
3. Nutra Pharma is already generating revenue with their Nyloxin®, Pet Pain-Away, and Equine Pain-Away in the over-the-counter pain management market, selling on different platforms such as Amazon, Walmart, and etc. They are selling worldwide in India as well.
4. Already granted Orphan Drug Status on their lead drug RPI-78M for treating Multiple Sclerosis in children.
5. All drugs completed Phase I trial and are ready for next phases II/III.
6. They have been working with private laboratories and governmental agencies to move forward their Nerve Agent Countermeasures and technology. Government grants and contracts are coming as stated in the shareholders letter by company.
7. Research partnership/joint ventures and funding to be announced regarding their lead drug RPI-78M for Multiple Sclerosis, HIV, ALS/AMN
8. In-house manufacturing of drug products including the future productions of RPI-78M. Turning into a cGMP manufacturing facility where the company will be able to make drugs for other drug companies.
9. Laboratory Upgrades, Certifications, and Expansions for the upcoming MS trials and the validation of company's nerve agent counter-measure.
10. Company regaining SEC compliance. Going for PINK and OTCQB status.
Going current, renewing all patents and trademarks. Hired the best SEC lawyers, auditors, and IP attorneys. All toxic notes paid. BIG Things coming!
See below:
Throughout 2021, we expect to continue actively marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away. We are currently working to begin a broad retail rollout that follows our acceptance at Walmart.com. These sales will bring in the revenue that will bring the company to profitability as well as provide the financing for the proposed clinical studies.
In 2021, we plan to begin working with joint venture partners to begin clinical trials with our Multiple Sclerosis (MS) drug, RPI-78M under our Orphan designation for pediatric MS. The Orphan status of the drug will allow for faster, less expensive trials as we lay the groundwork for the eventual drug production and trial protocol development. It is our goal to complete the Phase I/II trials in pediatric MS over the next 18-24 months and then either move into Phase III trials or seek a licensing partner.
We also plan to move forward with our work in nerve agent counter-measures and are filing for several grants with US governmental agencies to fund that work.
We believe that we have set the path for a bright future starting with 2021. Sales growth and marketing expansion will allow for a better market for our products and services. Marketing partnerships will bring in strategic investors with a vested interest in the future of our Company.
This will make 2021 our best year ever – for our shareholders, our customers and our patients.
.50-$1 coming
.011 bids vs .0125 asks freaking widespread. Shares locked and controlled.
2nd straight day with $1.6M+ traded volumes.
$1.6M dollar volumes today....more to come.
Are we breaking .02 today?!
Yes they are. Too big of a pipeline here for so many treatments.